The Drug Resistance Index (DRI) is an important tool to understand the development of drug resistance. About the latest trends we asked Dr. Eili Klein, fellow at the Center for Disease Dynamics, Economics & Policy, who is involved in the design and development of the Index. Mr. Klein, according to the Drug Resistance Index, the […]
The alert system ProMED reports quickly on outbreaks of emerging diseases around the globe – often times quicker than other well-known reporting systems. This can be explained by two main reasons: Informal reports on outbreaks can be made through a secure platform, and a worldwide staff of so-called subject matter experts is communicating on real-time […]
First steps towards a better hygiene- and surveillance system but: Still great challenges in Iranian hospitals regarding healthcare associated infections (HAI) and antimicrobial resistance (AMR). An exclusive insight in Iranian hospital hygiene conditions gave us Prof. Mehrdad Askarian, international hygiene expert at the university of Medical Sciences in Shiraz. The implementation of a good hygiene- […]
Transparency of infection numbers: Would cause a certain positive pressure but could foster defensive medicine. With Dr. Agnes Wechsler-Fördös from the antibiotics and infection control unit of the hospital Rudolfstiftung Vienna, spoke Carola Timmel. In connection with Infection Control and Antibiotic Stewardship the call for greater transparency can be heard again and again. Only few […]
Why are cross-border initiatives in the fight against AMR so important? We asked Prof. Alexander Friedrich, chair of the Department of Medical Microbiology and Infection Prevention, University Groningen. The initiator of the current EurSafety project is dealing with this item since the late 90s, when studies showed, that the prevalence rates of MRSA in countries […]
A recently published report from Eurosurveillance (Nov. 12) about carbapenemase producing enterobacteriaceae (CPE) in Europe states: Cases of this germs are showing a sharp rise. About details concerning this study we asked Dr. Thomas Hauer, medical director of the German consulting centre for hygiene in Freiburg. Mr. Hauer, what does carbapenemase producing mean exactly, and are […]
Rapid diagnostic tools are needed to fix antibiotic crisis: This ist the central message of a report recently published (October, 23) by the Review on Antimicrobial Resistance, chaired by Jim O’Neill. The paper with the title Rapid diagnostics: Stopping unnecessary use of antibiotics is an extensive compendium of valuable suggestions. “To avoid the tragedy of […]
A potential danger due to a reactivation of latent tuberculosis infection is mentioned in the current epidemiological bulletin of the Robert Koch Institute (RKI). Could this lead to a problem – and which medical challenges we have to face else in relation to the refugee issue? We asked Dr. Rainer Löb, Federal Doctor of Malteser […]
The IMB Centre for Superbug solutions at the University of Queensland, Australia, is one of the most important institutions dealing with drugs and diagnostics for superbugs. We spoke with the director of the Centre, Professor Matt Cooper. Mr. Cooper, some weeks ago I read an article in “theguardian” with the title “Resistance isn’t futile – […]
“It´s high time for an International Patient Safety Day”, thought the relevant institutions of the three countries Austria, Switzerland and Germany – and initiated one. The purpose is to signalize that patient safety takes a key role in medical care. We spoke with one of the initiators, Dr. Brititte Ettl, President of the Platform for […]
Carola Timmel
Carola Timmel
Carola Timmel
Carola Timmel
Carola Timmel
Carola Timmel
Carola Timmel
Carola Timmel